These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 16356813
21. Multiple hypervascular pancreatic metastases from renal cell carcinoma: dynamic MR and spiral CT in three cases. Ascenti G, Visalli C, Genitori A, Certo A, Pitrone A, Mazziotti S. Clin Imaging; 2004; 28(5):349-52. PubMed ID: 15471667 [Abstract] [Full Text] [Related]
22. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M. Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184 [Abstract] [Full Text] [Related]
23. [Magnetic resonance tomography for the detection and staging of kidney cancer]. Otvetchikov IN, Akhadov TA. Urol Nefrol (Mosk); 1996 Dec; (4):9-14. PubMed ID: 8928354 [Abstract] [Full Text] [Related]
24. [Chromophobe cell renal carcinoma: a case report]. Nakazawa M, Yamaguchi K, Ishizuka O, Nishizawa O. Hinyokika Kiyo; 1999 Mar; 45(3):179-82. PubMed ID: 10331170 [Abstract] [Full Text] [Related]
25. [The pathological/MR tomographic correlation and differential diagnosis of malignant kidney tumors]. Kreft B, Flacke S, Conrad R, Pauleit D, Bachmann R, Wardelmann E, Albers P, Schild H. Rofo; 1999 Aug; 171(2):106-12. PubMed ID: 10506883 [Abstract] [Full Text] [Related]
26. Imaging techniques for the patient with renal cell carcinoma. Gardner TA, Tirkes T, Mellon M, Koch MO. Semin Nephrol; 2011 May; 31(3):245-53. PubMed ID: 21784273 [Abstract] [Full Text] [Related]
27. The imaging evaluation of renal cell carcinoma: diagnosis and staging. McClennan BL, Deyoe LA. Radiol Clin North Am; 1994 Jan; 32(1):55-69. PubMed ID: 8284361 [Abstract] [Full Text] [Related]
28. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF. J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675 [Abstract] [Full Text] [Related]
29. Imaging in renal cell carcinoma. Krajewski KM, Giardino AA, Zukotynski K, Van den Abbeele AD, Pedrosa I. Hematol Oncol Clin North Am; 2011 Aug; 25(4):687-715. PubMed ID: 21763963 [Abstract] [Full Text] [Related]
30. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images. Thomson V, Pialat JB, Gay F, Coulon A, Voloch A, Granier A, Guérin JC, Viallon M, Berthezene Y. Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309 [Abstract] [Full Text] [Related]
31. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Rosen MA, Schnall MD. Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):770s-776s. PubMed ID: 17255308 [Abstract] [Full Text] [Related]
32. Current role and future perspective of MRI for diagnosis and characterization of renal cell carcinoma. Schoth F, Persigehl T, Palmowski M. Panminerva Med; 2010 Dec 15; 52(4):307-18. PubMed ID: 21183891 [Abstract] [Full Text] [Related]
33. Computed tomography and magnetic resonance imaging of adult renal cell carcinoma associated with Xp11.2 translocation. Dang TT, Ziv E, Weinstein S, Meng MV, Wang Z, Coakley FV. J Comput Assist Tomogr; 2012 Dec 15; 36(6):669-74. PubMed ID: 23192203 [Abstract] [Full Text] [Related]
34. Wilms' tumor and other pediatric renal masses. Siegel MJ, Chung EM. Magn Reson Imaging Clin N Am; 2008 Aug 15; 16(3):479-97, vi. PubMed ID: 18585600 [Abstract] [Full Text] [Related]
35. Three-dimensional fast spoiled gradient-echo dual echo (3D-FSPGR-DE) with water reconstruction: preliminary experience with a novel pulse sequence for gadolinium-enhanced abdominal MR imaging. Low RN, Panchal N, Vu AT, Knowles A, Estkowski L, Slavens Z, Ma J. J Magn Reson Imaging; 2008 Oct 15; 28(4):946-56. PubMed ID: 18821620 [Abstract] [Full Text] [Related]
36. Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies. Kondo T, Nakazawa H, Sakai F, Kuwata T, Onitsuka S, Hashimoto Y, Toma H. Int J Urol; 2004 Oct 15; 11(10):817-24. PubMed ID: 15479284 [Abstract] [Full Text] [Related]
37. Imaging characteristics of papillary renal cell carcinoma by computed tomography scan and magnetic resonance imaging. Tsuda K, Kinouchi T, Tanikawa G, Yasuhara Y, Yanagawa M, Kakimoto K, Ono Y, Meguro N, Maeda O, Arisawa J, Usami M. Int J Urol; 2005 Sep 15; 12(9):795-800. PubMed ID: 16201974 [Abstract] [Full Text] [Related]
38. [Significance of ultrasonography in detecting renal cell carcinoma]. Esa A, Takada M, Tsujihashi H, Park YC, Kaneko S, Akiyama T, Kurita T. Hinyokika Kiyo; 1989 Jun 15; 35(6):963-7. PubMed ID: 2678979 [Abstract] [Full Text] [Related]
39. The diagnosis, staging, and follow-up of carcinomas of the kidney, bladder, and prostate: the role of cross-sectional imaging. Singer J, McClennan BL. Semin Ultrasound CT MR; 1989 Dec 15; 10(6):481-97. PubMed ID: 2697358 [No Abstract] [Full Text] [Related]
40. State-of-the-art magnetic resonance imaging of pancreatic cancer. Schima W, Ba-Ssalamah A, Goetzinger P, Scharitzer M, Koelblinger C. Top Magn Reson Imaging; 2007 Dec 15; 18(6):421-9. PubMed ID: 18303400 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]